These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 33754376
21. The influence of HLA-DRB1*15 on the relationship between microglia and neurons in multiple sclerosis normal appearing cortical grey matter. Yates RL, Pansieri J, Li Q, Bell JS, Yee SA, Palace J, Esiri MM, DeLuca GC. Brain Pathol; 2022 Jul; 32(4):e13041. PubMed ID: 34904300 [Abstract] [Full Text] [Related]
22. Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis. Chomyk A, Kucinski R, Kim J, Christie E, Cyncynatus K, Gossman Z, Chen Z, Richardson B, Cameron M, Turner T, Dutta R, Trapp B. Ann Neurol; 2024 May; 95(5):907-916. PubMed ID: 38345145 [Abstract] [Full Text] [Related]
23. Unraveling the relationship between regional gray matter atrophy and pathology in connected white matter tracts in long-standing multiple sclerosis. Steenwijk MD, Daams M, Pouwels PJ, J Balk L, Tewarie PK, Geurts JJ, Barkhof F, Vrenken H. Hum Brain Mapp; 2015 May; 36(5):1796-807. PubMed ID: 25627545 [Abstract] [Full Text] [Related]
24. MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment. Filippi M. J Neurol; 2015 Jan; 262(1):1-6. PubMed ID: 24723117 [Abstract] [Full Text] [Related]
25. Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Bevan RJ, Evans R, Griffiths L, Watkins LM, Rees MI, Magliozzi R, Allen I, McDonnell G, Kee R, Naughton M, Fitzgerald DC, Reynolds R, Neal JW, Howell OW. Ann Neurol; 2018 Dec; 84(6):829-842. PubMed ID: 30362156 [Abstract] [Full Text] [Related]
26. White matter microglia heterogeneity in the CNS. Amor S, McNamara NB, Gerrits E, Marzin MC, Kooistra SM, Miron VE, Nutma E. Acta Neuropathol; 2022 Feb; 143(2):125-141. PubMed ID: 34878590 [Abstract] [Full Text] [Related]
27. Transcriptional profiling of human microglia reveals grey-white matter heterogeneity and multiple sclerosis-associated changes. van der Poel M, Ulas T, Mizee MR, Hsiao CC, Miedema SSM, Adelia, Schuurman KG, Helder B, Tas SW, Schultze JL, Hamann J, Huitinga I. Nat Commun; 2019 Mar 13; 10(1):1139. PubMed ID: 30867424 [Abstract] [Full Text] [Related]
28. Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis. Klaver R, Popescu V, Voorn P, Galis-de Graaf Y, van der Valk P, de Vries HE, Schenk GJ, Geurts JJ. J Neuropathol Exp Neurol; 2015 May 13; 74(5):453-8. PubMed ID: 25853695 [Abstract] [Full Text] [Related]
29. Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space. Howell OW, Schulz-Trieglaff EK, Carassiti D, Gentleman SM, Nicholas R, Roncaroli F, Reynolds R. Neuropathol Appl Neurobiol; 2015 Oct 13; 41(6):798-813. PubMed ID: 25421634 [Abstract] [Full Text] [Related]
30. Viscoelastic properties of white and gray matter-derived microglia differentiate upon treatment with lipopolysaccharide but not upon treatment with myelin. van Wageningen TA, Antonovaite N, Paardekam E, Brevé JJP, Iannuzzi D, van Dam AM. J Neuroinflammation; 2021 Mar 29; 18(1):83. PubMed ID: 33781276 [Abstract] [Full Text] [Related]
31. Microglia activation in periplaque white matter in multiple sclerosis depends on age and lesion type, but does not correlate with oligodendroglial loss. Kessler W, Thomas C, Kuhlmann T. Acta Neuropathol; 2023 Dec 29; 146(6):817-828. PubMed ID: 37897549 [Abstract] [Full Text] [Related]
32. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter. Peferoen LA, Gerritsen WH, Breur M, Ummenthum KM, Peferoen-Baert RM, van der Valk P, van Noort JM, Amor S. Acta Neuropathol Commun; 2015 Dec 22; 3():87. PubMed ID: 26694816 [Abstract] [Full Text] [Related]
33. Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study. Cappellani R, Bergsland N, Weinstock-Guttman B, Kennedy C, Carl E, Ramasamy DP, Hagemeier J, Dwyer MG, Patti F, Zivadinov R. AJNR Am J Neuroradiol; 2014 May 22; 35(5):912-9. PubMed ID: 24335548 [Abstract] [Full Text] [Related]
34. An updated histological classification system for multiple sclerosis lesions. Kuhlmann T, Ludwin S, Prat A, Antel J, Brück W, Lassmann H. Acta Neuropathol; 2017 Jan 22; 133(1):13-24. PubMed ID: 27988845 [Abstract] [Full Text] [Related]
35. CSF1R signaling is a regulator of pathogenesis in progressive MS. Hagan N, Kane JL, Grover D, Woodworth L, Madore C, Saleh J, Sancho J, Liu J, Li Y, Proto J, Zelic M, Mahan A, Kothe M, Scholte AA, Fitzgerald M, Gisevius B, Haghikia A, Butovsky O, Ofengeim D. Cell Death Dis; 2020 Oct 23; 11(10):904. PubMed ID: 33097690 [Abstract] [Full Text] [Related]
36. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Gray E, Thomas TL, Betmouni S, Scolding N, Love S. Brain Pathol; 2008 Jan 23; 18(1):86-95. PubMed ID: 18042261 [Abstract] [Full Text] [Related]
37. Multiple Sclerosis Pathology. Lassmann H. Cold Spring Harb Perspect Med; 2018 Mar 01; 8(3):. PubMed ID: 29358320 [Abstract] [Full Text] [Related]
38. The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. Mallucci G, Peruzzotti-Jametti L, Bernstock JD, Pluchino S. Prog Neurobiol; 2015 Apr 01; 127-128():1-22. PubMed ID: 25802011 [Abstract] [Full Text] [Related]
39. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant. Steenwijk MD, Geurts JJ, Daams M, Tijms BM, Wink AM, Balk LJ, Tewarie PK, Uitdehaag BM, Barkhof F, Vrenken H, Pouwels PJ. Brain; 2016 Jan 01; 139(Pt 1):115-26. PubMed ID: 26637488 [Abstract] [Full Text] [Related]
40. Prominent microglial activation in cortical white matter is selectively associated with cortical atrophy in primary progressive aphasia. Ohm DT, Kim G, Gefen T, Rademaker A, Weintraub S, Bigio EH, Mesulam MM, Rogalski E, Geula C. Neuropathol Appl Neurobiol; 2019 Apr 01; 45(3):216-229. PubMed ID: 29679378 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]